Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NQO2 | P16083 | 2/20 | 0.41 |
| ▸ | BACE1 | P56817 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.40 |
| ▸ | ERN1 | O75460 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.40 |
| ▸ | GAA | P10253 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | RAB9A | P51151 | 2/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.40 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.40 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.40 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.40 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.40 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23561088 | 0.89 | CA12 (0.42) | ALDH1A1MAPK1ERN1TSHRHSD17B10 | |
| SCHEMBL11792053 | 0.83 | RAB9A (0.49) | ALDH1A1MAPK1ERN1TSHRHSD17B10 | |
| SCHEMBL11799304 | 0.83 | CA12 (0.42) | BACE1ALDH1A1TSHRHSD17B10KDM4E | |
| SCHEMBL9200244 | 0.81 | SLC16A3 (0.45) | ALDH1A1HSD17B10GAAKDM4ERAB9A | |
| SCHEMBL8762164 | 0.81 | CA12 (0.47) | NQO2ALDH1A1MAPK1TSHRHSD17B10 | |
| SCHEMBL11788477 | 0.81 | ALDH1A1 (0.47) | ALDH1A1MAPK1TSHRHSD17B10KDM4E | |
| SCHEMBL18015088 | 0.80 | KDM4E (0.47) | NQO2ALDH1A1MAPK1TSHRHSD17B10 | |
| SCHEMBL30966775 | 0.80 | KDM4E (0.47) | NQO2ALDH1A1MAPK1TSHRHSD17B10 | |
| SCHEMBL21775704 | 0.78 | CA12 (0.62) | ALDH1A1MAPK1TSHRHSD17B10GAA | |
| SCHEMBL18373091 | 0.78 | ALDH1A1 (0.55) | ALDH1A1ERN1TSHRKDM4ESMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240326503-A1 | ON-PRESS DEVELOPMENT TYPE LITHOGRAPHIC PRINTING PLATE PRECURSOR, METHOD OF PREPARING LITHOGRAPHIC PRINTING PLATE, LITHOGRAPHIC PRINTING METHOD, AND COMPOUND | FUJIFILM CORPORATION (JP) | 2024-10-03 | — | — | US | disclosed |
| EP-4438300-A1 | ON-PRESS DEVELOPMENT TYPE LITHOGRAPHIC PRINTING PLATE PRECURSOR, METHOD OF PREPARING LITHOGRAPHIC PRINTING PLATE, LITHOGRAPHIC PRINTING METHOD, AND COMPOUND | FUJIFILM Corporation (JP) | 2024-10-02 | — | — | EP | disclosed |
| CN-118722043-A | On-press development type lithographic printing plate precursor, method for producing lithographic printing plate, lithographic printing method, and compound | 富士胶片株式会社 | 2024-10-01 | — | — | CN | disclosed |
| US-20230111853-A1 | COMPOUNDS MODULATING PROTEIN RECRUITMENT AND/OR DEGRADATION | ORIONIS BIOSCIENCES, INC. | 2023-04-13 | — | — | US | disclosed |
| WO-2021126973-A1 | COMPOUNDS MODULATING PROTEIN RECRUITMENT AND/OR DEGRADATION | ORIONIS BIOSCIENCES, INC. (US) | 2021-06-24 | — | — | WO | disclosed |
| EP-0453395-B1 | Pressure sensitive recording material | CIBA GEIGY AG (CH) | 1995-11-02 | — | — | EP | disclosed |
| US-5254522-A | Pressure-sensitive or heat-sensitive recording material | CIBA-GEIGY CORPORATION (US) | 1993-10-19 | — | — | US | disclosed |
| EP-0453395-A1 | Pressure sensitive recording material | CIBA-GEIGY AG (CH) | 1991-10-23 | — | — | EP | disclosed |
| US-4009193-A | OPTICAL BRIGHTENERS FOR ACRYLONITRILE POLYMERS | BASF AKTIENGESELLSCHAFT (DT) | 1977-02-22 | — | — | US | disclosed |
| US-3971821-A | Production of aminobenzaldehydes | BASF AKTIENGESELLSCHAFT (DT) | 1976-07-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230111853-A1 | COMPOUNDS MODULATING PROTEIN RECRUITMENT AND/OR DEGRADATION | CRBN, STUB1, ADRM1 | NQO2 4016/4885BACE1 234/4885ALDH1A1 4431/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.